Ultragenyx Pharmaceutical Inc.(RARE)
Biotechnology
Rare Disease / Orphan Drug
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-06-15 | Sanders Corazon (Corsee) D. Director | Sale | -2,000 | -8.66%21,095 | $25.05 | $50,100 | View SEC filing | |
| 2026-06-15 | Parschauer Karah Herdman EVP and Chief Legal Officer | Sale | -1,899 | -1.97%94,462 | $24.62 | $46,753 | View SEC filing | |
| 2026-06-01 | Horn Howard Chief Financial Officer | Sale | -4,653 | -4.22%105,689 | $23.77 | $110,602 | View SEC filing | |
| 2026-05-18 | SULIMAN SHEHNAAZ Director | Sale | -5,740 | -17.04%27,951 | $25.12 | $144,189 | View SEC filing | |
| 2026-05-06 | Crombez Eric EVP and Chief Medical Officer | Sale | -344 | -0.31%111,189 | $24.96 | $8,586 | View SEC filing | |
| 2026-05-04 | Horn Howard Chief Financial Officer | Sale | -4,683 | -4.07%110,342 | $24.90 | $116,607 | View SEC filing | |
| 2026-04-02 | Horn Howard Chief Financial Officer | Sale | -4,683 | -5.51%80,351 | $20.97 | $98,203 | View SEC filing | |
| 2026-03-10 | Parschauer Karah Herdman EVP and Chief Legal Officer | Sale | -9,526 | -12.48%66,820 | $21.87 | $208,312 | View SEC filing | |
| 2026-03-03 | Pinion John Richard See Remarks | Sale | -10,029 | -8.35%110,026 | $22.80 | $228,661 | View SEC filing | |
| 2026-03-03 | Harris Erik EVP & Chief Commercial Officer | Sale | -10,539 | -10.53%89,515 | $22.80 | $240,289 | View SEC filing | |
| 2026-03-03 | KAKKIS EMIL D President & CEO | Sale | -54,404 | -7.63%658,994 | $22.80 | $1,240,411 | View SEC filing | |
| 2026-03-03 | Parschauer Karah Herdman EVP and Chief Legal Officer | Sale | -8,135 | -9.63%76,346 | $22.80 | $185,478 | View SEC filing | |
| 2026-03-03 | Huizenga Theodore Alan SVP, Chief Accounting Officer | Sale | -1,632 | -3.24%48,670 | $22.80 | $37,210 | View SEC filing | |
| 2026-03-03 | Horn Howard Chief Financial Officer | Sale | -10,044 | -10.56%85,034 | $22.65 | $227,538 | View SEC filing | |
| 2026-03-03 | Crombez Eric EVP and Chief Medical Officer | Sale | -7,029 | -8.44%76,301 | $22.80 | $160,261 | View SEC filing | |
| 2026-02-03 | Horn Howard Chief Financial Officer | Sale | -3,061 | -3.33%88,935 | $23.56 | $72,117 | View SEC filing | |
| 2026-01-05 | Horn Howard Chief Financial Officer | Sale | -3,150 | -3.31%91,996 | $22.84 | $71,946 | View SEC filing | |
| 2025-12-30 | Huizenga Theodore Alan SVP, Chief Accounting Officer | Sale | -85 | -0.17%50,450 | $34.38 | $2,922 | View SEC filing | |
| 2025-12-11 | Horn Howard Chief Financial Officer | Sale | -3,081 | -3.14%95,146 | $36.38 | $112,087 | View SEC filing | |
| 2025-10-14 | Horn Howard Chief Financial Officer | Sale | -7,942 | -7.48%98,227 | $31.51 | $250,252 | View SEC filing | |
| 2025-09-19 | Huizenga Theodore Alan SVP, Chief Accounting Officer | Sale | -64 | -0.13%50,242 | $29.17 | $1,867 | View SEC filing | |
| 2025-09-12 | Parschauer Karah Herdman EVP and Chief Legal Officer | Sale | -2,450 | -3.24%73,271 | $31.17 | $76,367 | View SEC filing | |
| 2025-09-08 | Huizenga Theodore Alan SVP, Chief Accounting Officer | Sale | -84 | -0.17%50,306 | $31.39 | $2,637 | View SEC filing | |
| 2025-06-23 | Sanders Corazon (Corsee) D. Director | Sale | -2,405 | -13.55%15,344 | $37.39 | $89,923 | View SEC filing | |
| 2025-05-05 | Crombez Eric EVP and Chief Medical Officer | Sale | -762 | -0.55%71,530 | $37.93 | $28,901 | View SEC filing |
1-25 of 256